Ang-2-VEGF-A CrossMab, a novel bispecific human IgG1 antibody blocking VEGF-A and Ang-2 functions simultaneously, mediates potent antitumor, antiangiogenic …

…, E Lorenzon, D Bernicke, F Herting, S Yu… - Clinical Cancer …, 2013 - AACR
Purpose: VEGF-A blockade has been clinically validated as a treatment for human cancers.
Angiopoietin-2 (Ang-2) expression has been shown to function as a key regulator of tumor …

Effect of deformation twinning on microstructure and texture evolution during cold rolling of CP-titanium

YB Chun, SH Yu, SL Semiatin, SK Hwang - Materials Science and …, 2005 - Elsevier
The evolution of microstructure and texture during cold rolling of commercial-purity titanium (CP-Ti)
was studied with particular reference to deformation twinning and dislocation slip. For …

CMOS analog MAP decoder for (8, 4) Hamming code

C Winstead, J Dai, S Yu, C Myers… - IEEE Journal of Solid …, 2004 - ieeexplore.ieee.org
… Shuhuan Yu (S’01) received the BS degree in optical instrumentation and the MS degree in
test and measurement from Zhejiang University, China, in 1993 and 1998, respectively. She …

Nuclear factor-kappa B activation in skeletal muscle of patients with chronic heart failure: correlation with the expression of inducible nitric oxide synthase

…, U Späte, N Kränkel, SP Christian… - European Journal of …, 2003 - academic.oup.com
Background In the advanced stages of chronic heart failure (CHF) the expression of inducible
nitric oxide synthase (iNOS) in skeletal muscle (SM) may contribute to exercise intolerance …

Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

S Christian, J Pilch, ME Akerman, K Porkka… - The Journal of cell …, 2003 - rupress.org
A tumor-homing peptide, F3, selectively binds to endothelial cells in tumor blood vessels and
to tumor cells. Here, we show that the cell surface molecule recognized by F3 is nucleolin. …

Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma

…, S Daigle, J Davidson, K Bushell, S Yu… - Blood …, 2020 - ashpublications.org
Diffuse large B-cell lymphoma (DLBCL) patients are typically treated with immunochemotherapy
containing rituximab (rituximab, cyclophosphamide, hydroxydaunorubicin-vincristine (…

PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia

…, WH Roden, SA Gunter, SL Christian, S Collins… - Brain, 2015 - academic.oup.com
Malformations of cortical development containing dysplastic neuronal and glial elements,
including hemimegalencephaly and focal cortical dysplasia, are common causes of intractable …

Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females

…, E Gomez, I Nasrallah, J Minarcik, J Sudi, SL Christian… - Brain, 2009 - academic.oup.com
Mutations in the X-linked aristaless-related homeobox gene (ARX) have been linked to
structural brain anomalies as well as multiple neurocognitive deficits. The generation of Arx-…

[HTML][HTML] The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies

S Christian, C Merz, L Evans, S Gradl, H Seidel… - Leukemia, 2019 - nature.com
Acute myeloid leukemia (AML) is a devastating disease, with the majority of patients dying
within a year of diagnosis. For patients with relapsed/refractory AML, the prognosis is …

The Spectrum of Mutations in UBE3A Causing Angelman Syndrome

…, CS Benton, JS Sutcliffe, SL Christian… - Human molecular …, 1999 - academic.oup.com
Angelman syndrome (AS) is characterized by mental retardation, absence of speech,
seizures and motor dysfunction. AS is caused by maternal deletions for chromosome 15q11–q13, …